Michael Mason, VP, Finance and Treasurer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 8,000 shares at $60.77 ($483K) on 2013-12-16, disclosed to the SEC on 2013-12-18.
Scheduled sale ($483k) by VP, Finance and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.20 | 5,800 | $349K | 72.3% |
| 2 | $60.77 | 2,200 | $134K | 27.7% |
| Total | $60.36 avg | 8,000 | $483K | 100% |
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |